Bartosz Szostak

Dr. Bartosz Szostak

Lublin University of Technology
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KLKacper Lechowicz
Kacper Lechowicz
SDSylwester Drożdżal
Sylwester Drożdżal
FMFilip Machaj
Filip Machaj
Jakub RosikJakub Rosik
Jakub Rosik
BSBartosz Szostak
Bartosz Szostak
KKKatarzyna Laura Kotfis
Katarzyna Laura Kotfis
In December 2019, a novel coronavirus, SARS-CoV-2, appeared, causing a wide range of symptoms, mainly respiratory infection. In March 2020, the World Health Organization (WHO) declared Coronavirus Disease 2019 (COVID-19) a pandemic, therefore the efforts of scientists around the world are focused on finding the right treatment and vaccine for the novel disease. COVID-19 has spread rapidly over several months, affecting patients across all age groups and geographic areas. The disease has a diverse course; patients may range from asymptomatic to those with respiratory failure, complicated by acute respiratory distress syndrome (ARDS). One possible complication of pulmonary involvement in COVID-19 is pulmonary fibrosis, which leads to chronic breathing difficulties, long-term disability and affects patients’ quality of life. There are no specific mechanisms that lead to this phenomenon in COVID-19, but some information arises from previous severe acute respiratory syndrome (SARS) or Middle East respiratory syndrome (MERS) epidemics. The aim of this narrative review is to present the possible causes and pathophysiology of pulmonary fibrosis associated with COVID-19 based on the mechanisms of the immune response, to suggest possible ways of prevention and treatment.

26 July 2021 in Pharmacology Research & Perspectives
Verified
Journal Article
Open access
PDF file
SDSylwester Drożdżal
Sylwester Drożdżal
KLKacper Lechowicz
Kacper Lechowicz
BSBartosz Szostak
Bartosz Szostak
Jakub RosikJakub Rosik
Jakub Rosik
KKKatarzyna Kotfis
Katarzyna Kotfis
BGBarbara Gawrońska‐Szklarz
Barbara Gawrońska‐Szklarz
Nonsteroidal anti‐inflammatory drugs (NSAIDs) are widely available drugs with anti‐inflammatory and analgesic properties. Their mechanism of action is associated with the enzymes of the arachidonic acid cycle (cyclooxygenases: COX‐1 and COX‐2). The cyclooxygenase pathway results in the formation of prostanoids (prostaglandins [PGs], prostacyclins, and thromboxanes). It affects various structures of the human body, including the kidneys. Medical literature associates the usage of NSAIDs with acute kidney injury (AKI), tubulointerstitial nephritis (TIN), as well as nephrotic syndrome and chronic kidney disease (CKD). AKI associated with the chronic consumption of NSAIDs is mainly attributed to pharmacological polytherapy and the presence of cardiovascular or hepatic comorbidities. The pathomechanism of AKI and CKD is associated with inhibition of the biosynthesis of prostanoids involved in the maintenance of renal blood flow, especially PGE2 and PGI2. It is suggested that both COX isoforms play opposing roles in renal function, with natriuresis increased by COX‐1 inhibition followed by a drop in a blood pressure, whereas COX‐2 inhibition increases blood pressure and promotes sodium retention. TIN after NSAID use is potentially associated with glomerular basement membrane damage, reduction in pore size, and podocyte density. Therefore, nephrotic proteinuria and impairment of renal function may occur. The following article analyzes the association of NSAIDs with kidney disease based on available medical literature.

Verified
Journal Article
Open access
PDF file
KUKlaudia Ustianowska
Klaudia Ustianowska
ŁUŁukasz Ustianowski
Łukasz Ustianowski
FMFilip Machaj
Filip Machaj
AGAnna Gorący
Anna Gorący
Jakub RosikJakub Rosik
Jakub Rosik
APAndrzej Pawlik
Andrzej Pawlik
Understanding of the gut microbiome’s role in human physiology developed rapidly in recent years. Moreover, any alteration of this microenvironment could lead to a pathophysiological reaction of numerous organs. It results from the bidirectional communication of the gastrointestinal tract with the central nervous system, called the gut–brain axis. The signals in the gut–brain axis are mediated by immunological, hormonal, and neural pathways. However, it is also influenced by microorganisms in the gut. The disturbances in the gut–brain axis are associated with gastrointestinal syndromes, but recently their role in the development of different types of pain was reported. The gut microbiome could be the factor in the central sensitization of chronic pain by regulating microglia, astrocytes, and immune cells. Dysbiosis could lead to incorrect immune responses, resulting in the development of inflammatory pain such as endometriosis. Furthermore, chronic visceral pain, associated with functional gastrointestinal disorders, could result from a disruption in the gut microenvironment. Any alteration in the gut–brain axis could also trigger migraine attacks by affecting cytokine expression. Understanding the gut microbiome’s role in pain pathophysiology leads to the development of analgetic therapies targeting microorganisms. Probiotics, FODMAP diet, and fecal microbiota transplantation are reported to be beneficial in treating visceral pain.

29 June 2021 in Materials
Verified
Journal Article
Open access
PDF file
BSBartosz Szostak
Bartosz Szostak
Grzegorz GolewskiGrzegorz Golewski
Grzegorz Golewski
The use of fly ash in cement composites adversely affects its mechanical properties during the first days of mixture curing. Modern technology, in the form of an admixture containing the hydrated calcium silicates, allows to accelerate the hardening and binding process of concrete. In this paper, studies on the influence of the admixture on properties of concretes with the ordinary Portland cements (OPC) containing the addition of siliceous fly ash (FA) have been carried out. As part of the experimental research, the authors conducted a series of studies for cement pastes modified with the addition of FA and the CSH nano-admixture (NA). In order to compare the mixtures, the following tests of cement pastes were carried out: the compressive and flexural strength, heat of hydration, SEM and rheological shrinkage. The mechanical parameters were tested after 4, 8, 12 and 24 h. The hydration heat test and microstructure analysis were carried out during the first 24 h of the concrete curing. All tests were carried out on the standard samples. On the basis of the heat of hydration test, much higher hydration heat was found in mixtures modified with the NA. During the shrinkage test, a positive effect of the NA was observed—the shrinkage during the first 28 days of mixture curing was lower than in the reference samples. The application of the CSH nano-admixture to cement pastes with the addition of FA has brought positive effects. Apart from a significant increase in strength in the first 24 h of mixture curing, a reduction in the rheological shrinkage was observed. The admixture can be successfully used in the ash concretes, in which a higher early strength is required.

29 October 2021 in Materials
Verified
Journal Article
Open access
PDF file
Grzegorz GolewskiGrzegorz Golewski
Grzegorz Golewski
BSBartosz Szostak
Bartosz Szostak
Siliceous fly ash (FA) is the main additive to currently produced concretes. The utilization of this industrial waste carries an evident pro-ecological factor. In addition, such actions have a positive effect on the structure and mechanical parameters of mature concrete. Unfortunately, the problem of using FA as a Portland cement replacement is that it significantly reduces the performance of concretes in the early stages of their curing. This limits the possibility of using this type of concrete, e.g., in prefabrication, where it is required to obtain high-strength composites after short periods of curing. In order to minimize these negative effects, this research was undertaken to increase the early strength of concretes with FA through the application of a specifically formulated chemical nano-admixture (NA) in the form of seeds of the C-S-H phase. The NA was used to accelerate the strength growth in concretes. Therefore, this paper presents results of tests of modified concretes both with the addition of FA and with innovative NA. The analyses were carried out based on the results of the macroscopic and microstructural tests in five time periods, i.e., after 4, 8, 12, 24 and 72 h. The results of tests carried out with the use of NA clearly indicate the possibility of using FA in a wide range of management areas in sustainable concrete prefabrication.

21 December 2020 in Energies
Verified
Journal Article
Open access
PDF file
BSBartosz Szostak
Bartosz Szostak
Grzegorz GolewskiGrzegorz Golewski
Grzegorz Golewski
Modification of a cement matrix using additives and admixtures has been a common practice for many years. The use of some mineral additives as substitutes for the cement, e.g., the siliceous fly ashes (FAs), has a positive effect on reducing the energy used in cement production. On the other hand, such activities may have negative effects due to the lowering of strength parameters of composites in early stages of curing. In order to solve this problem, over the last few years, thanks to the patented "seedings" technology, a branch of industry connected with the production of admixtures that accelerate the binding process has developed significantly. Therefore, the paper presents the results of research aimed at analyzing the parameters of FA cement matrix with the nanoadmixture containing the nanometric C-S-H seeds (nanoadmixture (NA)). By using the modern NA, an attempt was made to neutralize the negative influence of the used industrial waste on the structure of the cement matrix in the early stages of its curing. The paper presents the results of strength tests for the FA cement pastes modified by NA in seven test periods, i.e., after 8, 12, 24 and 72 h, and 7, 14 and 28 days. Additionally, hydration heat tests were carried out on the analyzed material in the first 24 hours of curing.